1. [P1–020]: SCREENING FDA‐APPROVED COMPOUNDS IN A TREM2 CELL MODEL OF ALZHEIMER's DISEASE. (1st July 2017) Authors: Rutter, Hannah; Lim, Yau Mun; Corcoran, Jonathan; Hodges, Angela Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 4 Page Start: P240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P1–099]: SCREENING FDA‐APPROVED COMPOUNDS IN A TREM2 CELL MODEL OF ALZHEIMER's DISEASE. (1st July 2017) Authors: Rutter, Hannah; Lim, Yau Mun; Corcoran, Jonathan; Hodges, Angela Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 5 Page Start: P278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. [P1–208]: CRISPR/CAS9‐MEDIATED GENE EDITING OF TREM2 IN MONOCYTIC AND MICROGLIAL CELL LINES. (1st July 2017) Authors: Lim, Yau Mun; Rutter, Hannah; Killick, Richard; Hodges, Angela Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 6 Page Start: P322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗